ESTERN Medical CRO offers a full range of clinical trial research development in the areas of pharmaceutical and medical device development services across two continents US-North America & Latin America Phase I, II, III & IV
ESTERN Medical Offers an exceptional new breadth for Pharmaceutical & Medical Device R&D with an in-depth expertise across the entire clinical trials spectrum in two continents.
We’re proud to announce that Mr. Daniel Vazquez has joined ESTERN Medical CRO Life Sciences as the Head of Clinical Trials Regulatory Advisory Board.
The ESTERN Medical CRO Life Sciences & Consulting Group, a life science clinical trials, regulatory, quality and clinical consulting firm, recently announced the launch of its clinical R&D Articles Series, an interactive knowledge of publications articles circuit featuring ESTERN most experienced clinical scientific strategic thinkers.
Dr. Jorge Estrella, President & CMO at ESTERN Medical CRO Life Sciences, was part of virtual round table at The Economist Antibodies Inc: America’s Healthcare Revolution Virtual Roundtable meeting.
Within the past years, up to 78% of FDA-regulated clinical trials for the top pharmaceutical & medical device companies are conducted outside the U.S.
In the past 15 months, since the World Health Organization declared Covid-19 as a pandemic, healthcare systems around the globe have been under immense clinical trials R&D and regulatory pressure.
The United States has what is arguably the most complex healthcare system in the world. As a result, changes within the industry are slow. To understand what may come, it helps to have a deeper understanding of healthcare’s complexity.